{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098082","form_type":"8-K","ticker":"CYPH","cik":"0001509745","company_name":"CYPHERPUNK TECHNOLOGIES INC.","filed_at":"2025-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.591297+00:00","generated_at":"2026-05-17T04:10:51.734346+00:00","sec_items":["1.01","3.02","7.01","8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Leap Therapeutics closes $58.9M private placement led by Winklevoss Capital to pursue digital asset treasury","bullets":["Gross proceeds of ~$58.88M from sale of 15.2M shares, 80.8M pre-funded warrants, and 72.0M common warrants.","Winklevoss Capital leads the deal; gets right to nominate two board members, one of whom will serve as chair.","Proceeds to fund a digital asset treasury strategy and continue development of FL-501 and sirexatamab.","Common warrants priced at $0.5335/share, 10-year term; pre-funded warrants exercisable at $0.001/share with no expiration.","Parcrest serves as placement agent; receives $1.5M fee ($1M cash plus warrants for 4M shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098082","json":"https://secwatch.observer/filing/0001104659-25-098082.json","markdown":"https://secwatch.observer/filing/0001104659-25-098082.md","text":"https://secwatch.observer/filing/0001104659-25-098082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/0001104659-25-098082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/tm2528058d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:10:51.734346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3de43c8178f64f796a287560d31f258b96d5a10c","claim":"CYPHERPUNK TECHNOLOGIES INC. issued up to an aggregate of 80,768,504 shares of Common Stock of warrant to investors named therein for offering price of $0.51964 per Pre-Funded Warrant.","evidence_excerpt":"”) of (i) an aggregate of 15,212,311 shares (the “ Shares ”) of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at an offering price of $0.52064 per share, (ii) pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 80,768,504 shares of Common Stock (the “ Pre-Funded Warrant Shares ”) at an","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/0001104659-25-098082-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to an aggregate of 80,768,504 shares of Common Stock"},{"label":"Purchaser","value":"investors named therein"},{"label":"Consideration","value":"offering price of $0.51964 per Pre-Funded Warrant"}],"fact_type":"equity_issuance"},{"claim_id":"c1895367337de98542d2577bb9e478bc1b8886b4","claim":"CYPHERPUNK TECHNOLOGIES INC. issued 15,212,311 shares of common stock to investors named therein for $0.52064 per share.","evidence_excerpt":"”) of (i) an aggregate of 15,212,311 shares (the “ Shares ”) of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at an offering price of $0.52064 per share, (ii) pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 80,768,504 shares of Common Stock (the “ Pre-Funded Warrant Shares ”) at an","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/0001104659-25-098082-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"15,212,311 shares"},{"label":"Purchaser","value":"investors named therein"},{"label":"Consideration","value":"$0.52064 per share"}],"fact_type":"equity_issuance"},{"claim_id":"e19e8013e4f8b10b3fb54ccea804019cd6593c51","claim":"CYPHERPUNK TECHNOLOGIES INC. issued up to an aggregate of 71,985,605 shares of Common Stock of warrant to investors named therein for exercise price of $0.5335 per Common Warrant Share.","evidence_excerpt":"”) to purchase up to an aggregate of 71,985,605 shares of Common Stock (the “ Common Warrant Shares ”), each exercisable for one share of Common Stock at the exercise price of $0.5335 per Common Warrant Share. The Private Placement closed on October 8, 2025 (the “ Closing Date ”). The aggregate gross proceeds of the Private Placement were approximately USD","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/0001104659-25-098082-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to an aggregate of 71,985,605 shares of Common Stock"},{"label":"Purchaser","value":"investors named therein"},{"label":"Consideration","value":"exercise price of $0.5335 per Common Warrant Share"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}